Logged in as: Guest
WCN'24 Home
View detailed Congress Program
View Program at a glance
LOGIN
PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/665b491a4d7019e17f5290875a7fcfb6.pdf
Abstract Title
PHASE 3 COMMODORE TRIALS OF CROVALIMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): IMPACT ON KIDNEY FUNCTION
First Name *
Rocio
Last Name *
Soldati
Co-author 1
Sasha Sreckovic sreckovic.sasha@gene.com Genentech, Ltd PD Safety Risk Management San Fransisco
Co-author 2
Cristian Brocchieri cristian.brocchieri@roche.com F. Hoffmann-La Roche Ltd. Hematology and Nephrology Rare Diseases Basel
Co-author 3
Patty Leon leon.patty@gene.com Genentech, Ltd PDH Rare Blood Disorders San Francisco, CA
Co-author 4
Nadiesh Balachandran nadiesh.balachandran@roche.com F. Hoffmann-La Roche Ltd. Signal Detection, BPO Basel
Co-author 5
Marianne Uguen marianne.uguen@roche.com F. Hoffmann-La Roche Ltd. Signal Detection, BPO Basel
Co-author 6
Simon Buatois simon.buatois@roche.com F. Hoffmann-La Roche Ltd. Pharmaceutical Sciences Basel
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
